MedTrace Logo

TaiChi-DTx for Treating Long Covid Symptoms

NCT05419219 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2023-02-15

No results posted yet for this study

Summary

The randomized controlled trial will be conducted to evaluate the effectiveness of a Multi-domain Tai Chi Digital Therapy for treating the individuals suffering from the long term COVID-19 syndrome (Long COVID).

Conditions

Interventions

DEVICE

the multi-domain Tai Chi Digital therapy Software Application

regular Tai Chi exercise, 40 Hz gamma sound stimulation and 18 BPM breath control exercise

Sponsors & Collaborators

  • Tim Shi

    lead OTHER

Principal Investigators

  • Tim Shi, MD, PhD · GlobalMD Organization

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-06-01
Primary Completion
2023-05-31
Completion
2023-12-31
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05419219 on ClinicalTrials.gov